Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Profusaprofusa.comProfusa’s Lumee™ platform uses an injectable hydrogel microsensor to continuously monitor tissue oxygen and glucose levels in real time. Its Oxygen Platform targets Critical Limb Ischemia patients with intra-operative and 28-day post-operative monitoring, while the Glucose Platform enables up to 270 days of continuous glucose monitoring via a simple needle injection.
Parse Score
